NOV 17, 2015 8:00 AM PST

Unleashing the power of biobanks to drive translational science forward

Speakers
  • Biorefinery Scientist, Integrated Biobank of Luxembourg
    Biography
      Dr. Mathay's research background is molecular cell biology with a specialization in dermatology. She holds a PhD in Biomedical and Pharmaceutical Sciences from the University of Namur (Belgium).
      Her background includes "Specialized Studies in Applied Biological Sciences (DES)" including traineeships at the Karolinska Institutet in Stockholm and the Agricultural University of Gembloux (GxABT). She worked previously in transdisciplinary applied medical research projects from the Région Wallonne.
      In 2010, Dr. Mathay joined the Integrated Biobank of Luxembourg as Biorefinery Scientist. In IBBL she is organizing and supervising activities of the Biorefinery and Biospecimen Research laboratory and is deeply involved in Lab Automation, Quality Control and Validation of Analytical Laboratory Methods. Important publications include fundamental dermatology research publications and method validation papers.
      Dr. Mathay will discuss automation of nucleic acid extraction of two Biobanking workflows. The JANUS® chemagic automated workstation is a robust and quick magnetic beads-based nucleic acid extraction method which permits to process different sample types and volumes. The DNA extraction workflows were formally validated the DNA extraction workflows from human blood and stool and this presentation will illustrate the advantages of automated sample handling and extraction of DNA from blood and stool samples and their related formal method validation.
    • Professor of Genetics Rutgers University; COO RUCDR Infinite Biologics; CSO Brooks Life Sciences
      Biography
        Dr. Andy Brooks is the Chief Operating Officer and Director of Technology Development of RUCDR Infinite Biologics at Rutgers University. As the COO, Dr. Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services. RUCDR Infinite Biologics, is the world's largest university-based biorepository with a focus on creating and implementing technologies for biomaterial quality control and sample chain of custody. Dr. Brooks is a molecular neuroscientist, whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for both nucleic acid and protein analyses. He has worked to automate and develop the service infrastructure to provide high-throughput sample management and analysis for DNA, RNA, and protein-based technologies to hundreds of labs globally.
      • Director of Strategic Marketing, PerkinElmer Informatics
        Biography
          Jens Hoefkens oversees the non-clinical life science informatics portfolio at PerkinElmer. His responsibilities cover the TIBCO® Spotfire franchise, the Enterprise R&D collaboration platforms, and the Signals data management platform. Jens has over a decade of experience in running successful bioinformatics businesses with a special emphasis on drug discovery, translational research, and cross-OMICS data integration Prior to joining PerkinElmer, Jens was the Head of the Expressionist business unit at Genedata, where he managed all aspects of the business, including sales, marketing, services, and software development. In that role Jens successfully expanded the Expressionist product line to include support for Next Generation Sequencing and Mass Spectrometry data. Jens holds a dual major PhD in Mathematics and Physics from Michigan State University.
          In this webinar, Dr. Hoefkens will present PerkinElmer Signals® a cloud-based data management platform that has been designed with flexible and scalable data models to provide the scalability and agility required to support modern life science research. To illustrate the versatility of the platform, we look at examples in areas as varied as Translational Medicine and High Content Screening.

        Abstract
        DATE: November 17th, 2015
        TIME: 8am PDT, 11am EDT, 4pm GMT

        Biobanks provide important capacity to collect large genomic data sets intended to enable the study of genetic signatures of an identified population. An essential step in genetic research is the isolation of high quality DNA or RNA. Many downstream biobanking applications are adversely affected by untreated or poor quality sample. Large amounts of cellular or other contaminating materials in complex mixtures often hinder many of the subsequent reactions and techniques. Thus, a method for the efficient, reliable and reproducible isolation of nucleic acids from complex biological mixtures is essential. This webinar presents innovative nucleic acid extraction technologies that help ensure high purity, high yield DNA/RNA. Speakers will also offer techniques for remote analysis and comparison of resulting data by multiple research groups in a biobanking workflow.

        Show Resources
        You May Also Like
        NOV 16, 2020 8:00 AM PST
        C.E. CREDITS
        NOV 16, 2020 8:00 AM PST
        Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
        NOV 10, 2020 7:00 AM PST
        C.E. CREDITS
        NOV 10, 2020 7:00 AM PST
        DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
        OCT 29, 2020 6:00 AM PDT
        C.E. CREDITS
        OCT 29, 2020 6:00 AM PDT
        Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
        SEP 10, 2020 9:00 AM PDT
        C.E. CREDITS
        SEP 10, 2020 9:00 AM PDT
        Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
        DEC 02, 2020 8:00 AM PST
        C.E. CREDITS
        DEC 02, 2020 8:00 AM PST
        DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
        AUG 25, 2020 8:00 AM PDT
        C.E. CREDITS
        AUG 25, 2020 8:00 AM PDT
        DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
        Loading Comments...
        Show Resources
        Attendees
        • See more